Charles Schwab’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Charles Schwab’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-161,993	Closed	-$485K	–	3734
2022 Q1	$485K	Hold	161,993	–	–	﹤0.01%	3113
2021 Q4	$208K	Buy	161,993 +11,625	+8%	+$23.3K	﹤0.01%	3354
2021 Q3	$340K	Sell	150,368 -228,880	-60%	-$822K	﹤0.01%	3236
2021 Q2	$2.16M	Buy	379,248 +201,707	+114%	+$1.34M	﹤0.01%	2692
2021 Q1	$1.12M	Buy	177,541 +21,642	+14%	+$162K	﹤0.01%	2817
2020 Q4	$1.22M	Buy	+155,899	New	+$1.38M	﹤0.01%	2716

Charles Schwab's TLMD Position: Q2 2022 in Review

Charles Schwab sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 161,993 shares — an estimated $485K sold.

Charles Schwab first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $2.16M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Charles Schwab reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Charles Schwab sold 161,993 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $485K.
Charles Schwab first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Charles Schwab's SOC Telemed, Inc. Class A Common Stock position peaked at $2.16M in Q2 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.